Lek Launching Protein Modification Facility - opening event
Pharmaceutical company Lek, a subsidiary of Novartis's generics arm Sandoz, will open on Tuesday afternoon a new facility for the production of modified proteins
Pharmaceutical company Lek, a subsidiary of Novartis's generics arm Sandoz, will open on Tuesday afternoon a new facility for the production of modified proteins